HomePSTV • NASDAQ
add
Plus Therapeutics Inc
Nakaraang pagsara
$0.24
Sakop ng araw
$0.24 - $0.25
Sakop ng taon
$0.16 - $1.77
Market cap
42.15M USD
Average na Volume
4.90M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.37M | -3.19% |
Gastos sa pagpapatakbo | 4.17M | 33.33% |
Net na kita | -5.71M | -46.37% |
Net profit margin | -417.92 | -51.19% |
Kita sa bawat share | 0.00 | 100.00% |
EBITDA | -5.60M | -57.57% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 8.61M | 138.82% |
Kabuuang asset | 16.32M | 146.12% |
Kabuuang sagutin | 12.33M | -20.88% |
Kabuuang equity | 4.00M | — |
Natitirang share | 171.55M | — |
Presyo para makapag-book | 8.04 | — |
Return on assets | -82.04% | — |
Return on capital | -176.22% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -5.71M | -46.37% |
Cash mula sa mga operasyon | -6.26M | -416.68% |
Cash mula sa pag-invest | -1.08M | -1,782.81% |
Cash mula sa financing | 2.80M | — |
Net change in cash | -4.53M | -295.03% |
Malayang cash flow | -4.01M | -1,221.55% |
Tungkol
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®. Wikipedia
Itinatag
1996
Headquarters
Website
Mga Empleyado
28
